1. Long-term Functional and Oncologic Outcomes of Partial Adrenalectomy for Pheochromocytoma.
- Author
-
Gomella PT, Sanford TH, Pinto PA, Bratslavsky G, Metwalli AR, Linehan WM, and Ball MW
- Subjects
- Adult, Female, Humans, Male, Organ Sparing Treatments methods, Outcome and Process Assessment, Health Care, Postoperative Period, Reoperation methods, Reoperation statistics & numerical data, Retrospective Studies, Time, United States epidemiology, Watchful Waiting methods, Adrenal Gland Neoplasms congenital, Adrenal Gland Neoplasms epidemiology, Adrenal Gland Neoplasms pathology, Adrenal Gland Neoplasms surgery, Adrenalectomy adverse effects, Adrenalectomy methods, Adrenalectomy statistics & numerical data, Hormone Replacement Therapy methods, Hormone Replacement Therapy statistics & numerical data, Neoplasm Recurrence, Local diagnosis, Neoplasm Recurrence, Local surgery, Pheochromocytoma congenital, Pheochromocytoma epidemiology, Pheochromocytoma pathology, Pheochromocytoma surgery, Postoperative Complications epidemiology, Postoperative Complications prevention & control, Steroids administration & dosage
- Abstract
Objective: To evaluate the recurrence and functional outcomes in a primarily hereditary cohort of patients undergoing partial adrenalectomy for pheochromocytoma., Methods: A retrospective review from a prospectively managed database of patients undergoing partial adrenalectomy from 1995 to 2018 at the National Cancer Institute was performed. Local recurrence was defined as imaging evidence of a recurrent or de novo lesion on the operative side. Steroid dependency was defined as requiring daily steroid replacement at time of last follow-up., Results: One hundred and twenty-four partial adrenalectomies, removing 162 tumors, were performed in 107 patients. Most patients had a known hereditary predisposition to develop bilateral, multifocal, and recurrent pheochromocytoma. Median tumor size was 2 cm (interquartile range (IQR) 1.5-2.8). Median follow-up was 60 months (IQR 13-131). Local recurrence occurred in 17 patients (15.8%) and were managed with active surveillance or surgery. A single patient (1/106, 0.9%) developed metastatic spread of pheochromocytoma approximately 14 years after his first of 2 partial adrenalectomies and remains alive under active surveillance. Median time to recurrence was 71 months (IQR 26-127) with 10 patients (9.3%) requiring daily steroid replacement at time of last follow-up., Conclusion: Partial adrenalectomy offers excellent oncologic and functional outcomes, sparing most patients from lifelong steroid replacement therapy. Recurrences can be easily managed with repeat surgery or active surveillance via functional work-up and imaging. Partial adrenalectomy remains the recommended surgical management for patients pre-disposed to development of bilateral, multifocal and recurrent pheochromocytoma., (Published by Elsevier Inc.)
- Published
- 2020
- Full Text
- View/download PDF